Learning Objectives:

• Identify Newer FDA approved non-statin therapies, indications, and % LDL reduction.
• Describe treatment options for the truly statin-intolerant pt
• Determine to whom and when non-statins should be considered based on the percentage of LDL reduction or LDL range desired for the level of risk
• Choose which ones to consider and in what order

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.